Reading Time: 3 minutes In a guest blog, PhD student Oliver Clabburn tells us about his family’s experience of MND and his research interests. He also explains how you
Author: Research Information Team
The MND Association’s vision is a world free from MND. Realising this vision means investing more in research, further developing partnerships with the research community, funding bodies and industry, while ensuring that advances in understanding and treating MND are communicated as quickly and effectively as possible.
Reading Time: 2 minutes Today an exciting announcement was made about three organisations working together to increase our knowledge on the best way to provide palliative and end of
Reading Time: 3 minutes On Tuesday, we posted news of the two MND Awareness engagement events taking place in Manchester during the Manchester Science Festival (on 25 and 31
Reading Time: 3 minutes Manchester this half term will be the showcase for two MND awareness events we’ve been working on with Dr Emma Hodson-Tole and Dr Rickie Patani.
Reading Time: 5 minutes Results from the UK clinical trial of diaphragm pacing in MND/ALS (known as DiPALS) were published online today in the journal Lancet Neurology. DiPALS was
Reading Time: 3 minutes At present there is no diagnostic test for MND, and diagnosis is usually determined through clinical observations and by excluding other diseases. Because of this,
Reading Time: 5 minutes A question was submitted to the Association’s AGM last weekend, which could only be answered in brief at the time, due to the number of
Reading Time: 2 minutes To end MND Awareness month our final blog for our MND Research ‘blog a day’ is from Sally Light, CEO of the MND Association. After joining the Association back in
Reading Time: 2 minutes Barbara Thuss is project co-ordinator for Project MinE, an international initiative with the aim of sequencing at least 15,000 MND genomes. We announced earlier today that the
Reading Time: 3 minutes Medical Research Council (MRC)/ MND Association Lady Edith Wolfson Clinical Research Fellow, Dr Johnathan Cooper-Knock, is based at the Sheffield Institute for Translational Neuroscience (SITraN),